Fresh from Psychedelic Science 2025, Dr. Steve Levine, the chief patient officer at Compass Pathways, talks to us about new Phase 3 results for psilocybin in treating depression.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
